Zomedica Pharmaceuticals Corphares (NYSEAMERICAN:ZOM) Shorts Increased By 17.49% As Of Jun 29, 2018

June 29, 2018 - By Theresa McIntyre

Change of 17.49% for Zomedica Pharmaceuticals Corphares (NYSEAMERICAN:ZOM)’s shorted shares was showed. In June was published ZOM’s total 52,400 shorted shares by FINRA. The 44,600 previous shares are up with 17.49%. With Average volume 13,200, ZOM’s previous position will take 4 days to restore. 0.24% is Zomedica Pharmaceuticals Corphares float short.

The stock increased 0.90% or $0.02 during the last trading session, hitting $2.25.Zomedica Pharmaceuticals Corp. has volume of 2,574 shares. Since June 29, 2017 ZOM has 0.00% and is . ZOM underperformed the S&P500 by 12.57%.

Zomedica Pharmaceuticals Corp. operates as a veterinary pharmaceutical firm in the United States.The firm is valued at $189.46 million. It focuses on the discovery, development, and commercialization of drugs, novel drug delivery systems, devices, and diagnostics for the health and wellness of companion animals, such as canine, feline, and equine.Last it reported negative earnings. The firm has a research collaboration agreement with Celsee Diagnostics, Inc. to test the feasibility of Celsee's liquid biopsy technology for veterinary application as a canine cancer diagnostics.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.